Why Would Insurance Deny an MRI?

Insurance companies deny MRI requests when they determine the scan does not meet their criteria for medical necessity, which usually means the clinical information submitted does not match the insurer’s guidelines for when imaging is warranted. About 5% of MRI prior authorization requests are denied in large orthopedic datasets, though the rate varies by body part, insurer, and diagnosis. The reasons behind a denial range from straightforward paperwork errors to more contentious judgments about whether you have tried enough non-imaging treatments first, and understanding those reasons is the first step toward getting the scan approved.

Prior Authorization Is the Gatekeeper

Most MRI denials are not outright rejections of coverage. They are denials of prior authorization, the approval step your insurer requires before the scan can happen. When your doctor orders an MRI, someone in the office typically submits a request to the insurance company that includes your diagnosis, symptoms, and relevant clinical history. A reviewer on the insurance side then checks that information against a set of clinical guidelines to decide whether the scan is justified for your situation.

Insurers contract with companies called radiology benefits management firms to run these programs. These firms operate call centers where staff compare the submitted clinical details against evidence-based appropriateness criteria. The stated goal is to slow the growth of advanced imaging use and steer patients away from scans that are unlikely to change their treatment plan. Research on one such program found that prior authorization did appear to slow the growth in utilization of MRI, CT, and PET scanning in a large commercial insurance market.

Whether that slower growth represents eliminated waste or delayed necessary care depends on who you ask. But from the patient’s perspective, the practical effect is the same: your doctor ordered a test, and the insurance company said not yet or not at all.

Medical Necessity and Appropriateness Criteria

The phrase you will see on a denial letter more than any other is “not medically necessary.” This does not mean the insurer thinks nothing is wrong with you. It means the clinical information provided did not match the specific criteria the insurer uses to approve that particular scan for that particular diagnosis. These criteria are drawn from published clinical guidelines, and they can be surprisingly specific about what symptoms, exam findings, or prior test results need to be documented before an MRI is considered appropriate.

For example, clinical practice guidelines recommend against routine imaging for uncomplicated low back pain, particularly in the first several weeks when most cases improve on their own. If your doctor submits a request for a lumbar MRI and the only documented reason is “low back pain” without red-flag symptoms like neurological deficits, unexplained weight loss, or a history of cancer, the request will almost certainly be denied. This is not the insurer being arbitrary; it aligns with what major medical organizations recommend.

Similarly, MRI is not considered beneficial for joint pain in patients who already have clear osteoarthritis on X-rays, because the MRI findings rarely change the treatment approach. Insurers use this kind of evidence to build their approval algorithms.

A study evaluating outpatient CT and MRI orders from primary care clinics at an academic medical center applied radiology benefit management criteria to those orders and found that a meaningful share would not have met the threshold for approval, highlighting how frequently orders in routine practice fall outside evidence-based guidelines.

⁴

The Conservative Treatment Requirement

One of the most frustrating reasons for denial, especially for musculoskeletal problems, is the requirement that you try conservative treatment first. For shoulder pain that is not caused by a clear traumatic injury, insurers often mandate six weeks of physical therapy within the past twelve weeks before they will authorize an MRI.

⁵

The logic behind this is that many soft-tissue problems improve with physical therapy regardless of what an MRI would show, so the scan would not change the initial treatment plan. But the frustration for patients and surgeons is real: if an orthopedic surgeon examines your shoulder and strongly suspects a rotator cuff tear, being told to spend six more weeks in physical therapy before the insurer will approve a scan feels like a forced delay. The study that documented this requirement also examined how often orthopedic surgeons’ clinical suspicions turned out to be correct once the MRI was finally done, raising questions about whether the mandatory waiting period helps or just postpones the inevitable.

Similar conservative treatment requirements apply to knee pain, back pain, and other common musculoskeletal complaints. The threshold varies by insurer and sometimes by the specific plan, but the pattern is consistent: your insurer wants documentation that less expensive interventions were tried before authorizing a more expensive diagnostic test.

Which Body Parts Get Denied Most

Not all MRI requests face the same scrutiny. A large study of over 17,900 MRI prior authorization requests in an orthopedic setting found that about 5% were denied overall, but spine MRIs were significantly less likely to be authorized compared with scans of the shoulder, knee, upper extremity, lower extremity, and foot and ankle.

⁶

The spine stands out partly because of the guideline issue described earlier: low back pain is extremely common, most episodes resolve without imaging, and clinical guidelines explicitly discourage early MRI in the absence of red-flag symptoms. Insurers lean heavily on those guidelines when reviewing spine MRI requests. Meanwhile, a knee MRI ordered after a sports injury with a physical exam suggesting a torn ligament faces a more straightforward path to approval because the clinical scenario more cleanly fits the appropriateness criteria.

This difference matters practically. If you have been denied a spine MRI, your doctor may need to provide more detailed documentation of specific neurological findings, failed conservative treatment, or other clinical red flags. A denial for a spine MRI is not necessarily the insurer being unreasonable; it may reflect how strong the clinical evidence is against routine early imaging for back pain.

Paperwork Problems and Coding Errors

Sometimes a denial has nothing to do with whether the MRI is clinically appropriate. The request can be denied because of administrative errors: the wrong diagnosis code was submitted, required clinical notes were not attached, the referring physician’s information was incomplete, or the authorization request was filed after the scan was already performed. These are not clinical judgments but clerical failures, and they are fixable.

The coding and billing system for imaging is complex, involving diagnostic codes that describe your condition and procedure codes that describe the specific scan being requested. If the diagnosis code submitted does not match the insurer’s criteria for the requested scan type, the system may auto-deny the request even though a different code for the same condition would have sailed through. This is why it is worth asking your doctor’s office to double-check the submitted codes when you receive a denial. In many cases, resubmitting with corrected information resolves the issue without an appeal.

Your Insurance Plan Matters More Than You Think

The same MRI request submitted to two different insurers can get two different results. The large orthopedic study mentioned earlier found that Medicaid plans were significantly less likely to authorize MRI requests compared with commercial insurers. Two Medicaid-affiliated plans had notably higher denial rates than Aetna or United Healthcare for the same types of scans.

⁶

Interestingly, the study did not find statistically significant differences in denial rates by patient race or socioeconomic status after accounting for insurance type. The insurance plan itself was the key variable. This suggests the disparity is baked into the plan’s authorization criteria and administrative processes rather than into individual case-by-case decision-making.

The downstream effects of plan type extend beyond just getting the authorization. A pediatric study found that children with Medicaid coverage experienced slower completion times for outpatient MRIs even after adjusting for other factors. Children whose families spoke a primary language other than English also faced longer waits.

⁷

Whole-Body and Screening MRIs

If you are seeking an MRI not because of a specific symptom but as a general screening tool, expect your insurer to deny it. Whole-body MRI screening for average-risk individuals has gained attention through direct-to-consumer companies marketing full-body scans for early disease detection, but the clinical utility and cost-effectiveness of large-scale screening MRI have not been established.

⁸

Insurance companies cover diagnostic tests, not fishing expeditions. A diagnostic MRI addresses a specific clinical question based on your symptoms and exam. A screening MRI in someone with no symptoms is a fundamentally different proposition, and insurers treat it as experimental or investigational. If you want a whole-body scan, you will almost certainly be paying out of pocket.

What Happens When You Push Back

A denial is not the end of the road. Most insurance plans have a multi-step appeals process, and the evidence strongly suggests that pushing back works, especially at the peer-to-peer review stage. Peer-to-peer review is when your doctor speaks directly with a physician reviewer at the insurance company to make the case for the scan.

A study of orthopedic MRI and CT denials found that when cases reached peer-to-peer review, roughly 95% were ultimately approved. The reviewers were always physicians, but none whose specialty was identified were orthopedic surgeons, and only about 72% reported having reviewed the patient’s clinical notes before the call. The median time from the initial visit to the peer-to-peer review was nine days, and the median time from the visit to actually getting the scan was about two weeks for approved cases.

⁹

That 95% approval rate after peer-to-peer review is a striking number. It suggests that in the vast majority of cases where a specialist orders an MRI and the insurer initially denies it, the scan was clinically appropriate all along. The denial functioned not as a genuine clinical checkpoint but as a speed bump that delayed care by about two weeks without ultimately changing the outcome. The researchers characterized it bluntly: patient care was delayed, and reform is needed to improve the efficiency of the process.

If peer-to-peer review does not work, you still have options. Most plans offer an internal appeal where additional documentation can be submitted, and after that, many states require insurers to offer an external review by an independent physician who is not employed by the insurance company. Research on advanced shoulder imaging found that prior authorizations added cost and time burdens to the healthcare system while delaying intervention.

¹⁰

The Real Cost of Delays

Prior authorization delays are not just an inconvenience. A systematic review examining harmful effects of prior authorization across multiple specialties found that the process was associated with disease exacerbation, preventable hospitalization, prolonged hospital stays, and lower rates of disease-free survival. These harms spanned oncology, cardiology, behavioral health, and pediatrics.

¹¹

For MRI specifically, the concern is that a two-week or longer delay in diagnosis can mean a two-week or longer delay in treatment. For a suspected rotator cuff tear, that might mean additional weeks of pain and muscle atrophy. For a suspected spinal cord compression, the stakes are higher. The prior authorization system was designed to prevent unnecessary tests, but the evidence increasingly shows that its blunt application causes measurable harm.

AI-Driven Denials

A newer wrinkle in the denial landscape is the use of artificial intelligence to process prior authorization requests. Reports of AI-assisted blanket denials have increased in recent years, particularly in Medicare Advantage plans. Insurers using these systems have faced class action lawsuits, congressional investigations, and criticism from major healthcare providers.

¹²

The concern with AI-driven review is that automated systems may issue denials without a physician ever reviewing the patient’s actual clinical record. When the criteria are applied rigidly by an algorithm that cannot account for clinical nuance, appropriate requests get caught in the same net as inappropriate ones. If you receive a denial that seems to ignore the specific details of your case, an AI-generated decision may be the reason, and pushing for human physician review through the peer-to-peer process becomes even more important.

Paying Cash Can Sometimes Be Cheaper

If your MRI is denied and the appeal process stalls, or if you simply cannot afford the delay, paying out of pocket is an option worth investigating. MRI prices vary enormously depending on where you go. A study of shoulder MRI pricing found that hospital-owned imaging centers charged an average of about $2,060 compared with roughly $1,400 at independent imaging centers.

¹³

The price gap is not trivial, and the variation gets even more interesting when you consider cash pricing. A study of imaging facilities in the San Francisco Bay Area found that patients could save between 10% and 22% of their insurer’s in-network price by simply paying cash. If patients also shopped across facilities for the lowest available price in their area, potential savings jumped to 45% to 64% off the insurer’s negotiated rate.

¹⁴

This counterintuitive finding, that bypassing insurance entirely can cost less than using it, exists because insurers negotiate rates with hospitals that include overhead and administrative costs, while cash prices at standalone imaging centers strip much of that away. A separate study of a price transparency program found that when patients were shown the price differences among available MRI facilities, costs per test dropped by about 19% and use of hospital-based facilities declined.

¹⁵

If you go the cash route, call standalone imaging centers directly and ask for their self-pay price. Many will quote you a price over the phone that is a fraction of what shows up on an insurance-processed bill. Keep in mind that paying cash means the scan will not count toward your deductible, so weigh that against the delay and hassle of fighting the denial through the appeals process.

Legislative Reforms on the Horizon

The frustration around prior authorization has reached lawmakers. State and federal policymakers have been targeting prior authorization practices across commercial insurance, Medicare Advantage, and Medicaid. Proposals include shortening the turnaround time for authorization decisions, increasing transparency around denial rates, requiring that peer-to-peer reviewers be physicians in the same specialty as the ordering doctor, and establishing “gold-carding” programs that exempt clinicians with consistently high approval rates from the prior authorization requirement altogether.

¹⁶

Gold-carding is a particularly promising idea. If an orthopedic surgeon’s MRI requests are approved 97% of the time, requiring that surgeon to submit each request through prior authorization wastes everyone’s time and delays care for patients. Some states have already enacted gold-carding laws, though the details of implementation vary. Clinical decision support tools built into the ordering process are another approach: rather than having an insurer review the order after the fact, the software guides the physician toward evidence-based ordering at the point of care, which has been shown to reduce orders for low-value imaging like lumbar MRI for uncomplicated back pain and head MRI for routine headache.

¹⁷

These reforms acknowledge something the data already shows: the current prior authorization system catches a small number of genuinely inappropriate orders at the cost of delaying care for the overwhelming majority of appropriate ones. Whether the political will exists to meaningfully change the system remains an open question, but the direction of policy is clearly toward reducing the burden on patients and physicians rather than expanding it.